Life Sciences Industry in Israel Soars.
A comprehensive report by Israel Advanced Technology Industries and PwC on the life sciences industry in Israel has shown significant growth. The sector currently has 1,450 active companies compared to 800-900 five years ago. A record $1.2 billion was raised in 2017 from local and foreign funds, public offerings, investments by private equity funds, and support from the Israel Innovation Authority. The capital raising was 40 percent higher than in 2016 and 400 percent more than a decade ago. According to the report, $656 million was raised in rounds of more than $20 million last year, compared to $452 million in 2016.
This increase was significant because larger financing rounds enable drug companies to conduct advanced clinical trials and companies with less complex medical devices to build marketing apparatuses.